EPIVARIN Trademark

Trademark Overview


On Saturday, April 5, 2014, a trademark application was filed for EPIVARIN with the United States Patent and Trademark Office. The USPTO has given the EPIVARIN trademark a serial number of 86243559. The federal status of this trademark filing is CANCELLED - SECTION 8 as of Friday, November 26, 2021. This trademark is owned by GW Pharma Limited. The EPIVARIN trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations and substances for the treatment of pain, neuropathic pain, cancer pain, peri-operative pain, oncology, cancer symptoms, multiple sclerosis, spasticity, MS spasticity, convulsions, seizures, epilepsy, paediatric epilepsy, intractable childhood epilepsy with generalized tonic-clonic seizures (ICE-GTC), generalized epilepsy with febrile seizures plus (GEFS+), dup 15, and Doose syndrome, bladder disfunction, inflammatory bowel disease, ulcerative colitis, Crohn's disease, Alzheimer's, Dravet syndrome, Lennox-Gastaut syndrome (LGS), spinal cord injury, head injury, bone disorders, chromosome disorders, inflammatory disorders, inflammation, arthritis, metabolic disorders, oncology, cancer symptoms, neurodegenerative diseases, diseases of the central nervous system, peripheral neuropathy, neurogenic symptoms, hypoxicischemic encephalopathy, neonatal hypoxic encephalopathy, stroke, motion sickness and chemically induced sickness, diabetes, type II diabetes, obesity...
epivarin

General Information


Serial Number86243559
Word MarkEPIVARIN
Filing DateSaturday, April 5, 2014
Status710 - CANCELLED - SECTION 8
Status DateFriday, November 26, 2021
Registration Number4726412
Registration DateTuesday, April 28, 2015
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, February 10, 2015

Trademark Statements


Goods and ServicesPharmaceutical preparations and substances for the treatment of pain, neuropathic pain, cancer pain, peri-operative pain, oncology, cancer symptoms, multiple sclerosis, spasticity, MS spasticity, convulsions, seizures, epilepsy, paediatric epilepsy, intractable childhood epilepsy with generalized tonic-clonic seizures (ICE-GTC), generalized epilepsy with febrile seizures plus (GEFS+), dup 15, and Doose syndrome, bladder disfunction, inflammatory bowel disease, ulcerative colitis, Crohn's disease, Alzheimer's, Dravet syndrome, Lennox-Gastaut syndrome (LGS), spinal cord injury, head injury, bone disorders, chromosome disorders, inflammatory disorders, inflammation, arthritis, metabolic disorders, oncology, cancer symptoms, neurodegenerative diseases, diseases of the central nervous system, peripheral neuropathy, neurogenic symptoms, hypoxicischemic encephalopathy, neonatal hypoxic encephalopathy, stroke, motion sickness and chemically induced sickness, diabetes, type II diabetes, obesity, obesity associated with diabetes, bulimia, psychiatric disorders, schizophrenia, and drug, alcohol and nicotine abuse, autism; herbs for medicinal purposes; medicinal herbs; medicinal oils; medicinal infusions for treating pain, neuropathic pain, cancer pain, peri-operative pain, oncology, cancer symptoms, multiple sclerosis, spasticity, MS spasticity, convulsions, seizures, epilepsy, paediatric epilepsy, intractable childhood epilepsy with generalized tonic-clonic seizures (ICE-GTC), generalized epilepsy with febrile seizures plus (GEFS+), dup 15, and Doose syndrome, bladder disfunction, inflammatory bowel disease, ulcerative colitis, Crohn's disease, Alzheimer's, Dravet syndrome, Lennox-Gastaut syndrome (LGS), spinal cord injury, head injury, bone disorders, chromosome disorders, inflammatory disorders, inflammation, arthritis, metabolic disorders, oncology, cancer symptoms, neurodegenerative diseases, diseases of the central nervous system, peripheral neuropathy, neurogenic symptoms, hypoxicischemic encephalopathy, neonatal hypoxic encephalopathy, stroke, motion sickness and chemically induced sickness, diabetes, type II diabetes, obesity, obesity associated with diabetes, bulimia, psychiatric disorders, schizophrenia, and drug, alcohol and nicotine abuse, autism; pure extracts of medicinal plants and herbs for medical, veterinary and pharmaceutical purposes; foodstuffs for medicinal purposes, namely, medicated supplements for foodstuffs for babies and animals; herb teas for medicinal purposes

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code2 - Sec. 8 - Entire Registration
Class Status DateFriday, November 26, 2021
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameGW RESEARCH LIMITED
Party Type31 - New Owner After Registration
Legal Entity Type99 - Other
AddressCAMBRIDGE CB249BZ
GB

Party NameGW Pharma Limited
Party Type30 - Original Registrant
Legal Entity Type03 - Corporation
AddressCambridge CB249BZ
GB

Party NameGW Pharma Limited
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressSalisbury SP4OJR
GB

Party NameGW Pharma Limited
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressSalisbury SP4OJR
GB

Trademark Events


Event DateEvent Description
Friday, November 26, 2021CANCELLED SEC. 8 (6-YR)
Wednesday, September 15, 2021TEAS CHANGE OF CORRESPONDENCE RECEIVED
Wednesday, September 15, 2021TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS
Wednesday, September 15, 2021ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Wednesday, September 15, 2021TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Wednesday, July 28, 2021ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY
Tuesday, April 28, 2020COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
Wednesday, July 25, 2018AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
Tuesday, December 12, 2017APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Tuesday, December 12, 2017TEAS CHANGE OF OWNER ADDRESS RECEIVED
Wednesday, November 29, 2017ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Wednesday, November 29, 2017TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Tuesday, April 28, 2015REGISTERED-PRINCIPAL REGISTER
Tuesday, February 10, 2015OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, February 10, 2015PUBLISHED FOR OPPOSITION
Wednesday, January 21, 2015NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Wednesday, January 7, 2015LAW OFFICE PUBLICATION REVIEW COMPLETED
Wednesday, January 7, 2015APPROVED FOR PUB - PRINCIPAL REGISTER
Monday, December 29, 2014TEAS/EMAIL CORRESPONDENCE ENTERED
Monday, December 29, 2014CORRESPONDENCE RECEIVED IN LAW OFFICE
Monday, December 29, 2014ASSIGNED TO LIE
Friday, December 12, 2014TEAS RESPONSE TO OFFICE ACTION RECEIVED
Monday, June 23, 2014NOTIFICATION OF NON-FINAL ACTION E-MAILED
Monday, June 23, 2014NON-FINAL ACTION E-MAILED
Monday, June 23, 2014NON-FINAL ACTION WRITTEN
Friday, June 20, 2014ASSIGNED TO EXAMINER
Friday, April 18, 2014NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM
Wednesday, April 9, 2014NEW APPLICATION ENTERED IN TRAM